The Foot and Ankle Ability Measure (FAAM) is Translated From English to Turkish and Assess the Validity and Reliability in Athletic Population Who Have Foot and Ankle Disorders.

NCT03259750 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 51

Last updated 2017-08-24

No results posted yet for this study

Summary

Sport activity induces a relevant risk for lower extremities especially ankle and foot structures. Athletes who participate in basketball, volleyball and soccer are predisposed. Self-reported outcome instruments have been used by clinicians to assess the treatment interventions effectiveness directed at patients with pathologies and identify impairments, disabilities and quality of life. The assessment of musculoskeletal injuries can be problem without clinical, radiological examination and on scores from patient-based questionnaires. The information from these questionnaires provides us good evidence if there is not interpretation of obtained scores. The Foot and Ankle Ability Measure (FAAM) is a self-reported outcome instrument for patients with foot and ankle disorders available in English, German, and French. The FAAM has a sports subscale and activity of daily living (ADL) subscale that can assess the activities that requires higher level. The aim of this study is to translate the FAAM into Turkish language, perform a cross-cultural adaptation, and investigate the reliability, validity of the translated version in athletic population

Conditions

  • Ankle; Injury, Superficial, Multiple (With Foot)

Interventions

OTHER

Foot and Ankle Ability Measure Turkish version (FAAM-T) questionnaire

Self reported outcome instrument

Sponsors & Collaborators

  • Serkan Usgu

    lead OTHER

Principal Investigators

  • Serkan Usgu, PhD · Hasan Kalyoncu University

  • Yavuz Yakut, Prof · Hasan Kalyoncu University

  • Sıdıka Fatma Uygur, Prof · Cyprus International University

  • Gunseli Usgu, PhD · Hasan Kalyoncu University

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-20
Primary Completion
2014-05-20
Completion
2015-07-12

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03259750 on ClinicalTrials.gov